These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential cytopathicity and susceptibility of Ghanaian highly divergent HIV-2 -GH2-, prototype HIV-2 -GH1-, and prototype HIV-1 -GH3- to inhibition by ddCyd and ddIno. Ayisi NK East Afr Med J; 1995 Oct; 72(10):654-7. PubMed ID: 8904046 [TBL] [Abstract][Full Text] [Related]
3. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. Pauwels R; Balzarini J; Baba M; Snoeck R; Schols D; Herdewijn P; Desmyter J; De Clercq E J Virol Methods; 1988 Aug; 20(4):309-21. PubMed ID: 2460479 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet. Koshida R; Vrang L; Gilljam G; Harmenberg J; Oberg B; Wahren B Antimicrob Agents Chemother; 1989 May; 33(5):778-80. PubMed ID: 2526616 [TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition of human immunodeficiency virus isolates (including 3'-azido-3'-deoxythymidine-resistant isolates) by foscarnet in combination with 2',3'-dideoxyinosine or 2',3'-dideoxycytidine. Palmer S; Harmenberg J; Cox S Antimicrob Agents Chemother; 1996 May; 40(5):1285-8. PubMed ID: 8723486 [TBL] [Abstract][Full Text] [Related]
6. In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine. Hostetler KY; Hammond JL; Kini GD; Hostetler SE; Beadle JR; Aldern KA; Chou TC; Richman DD; Mellors JW Antivir Chem Chemother; 2000 May; 11(3):213-9. PubMed ID: 10901292 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1. Koshida R; Cox S; Harmenberg J; Gilljam G; Wahren B Antimicrob Agents Chemother; 1989 Dec; 33(12):2083-8. PubMed ID: 2533474 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1. Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2',3'-dideoxy-3'-thiacytidine conjugates. Charvet AS; Camplo M; Faury P; Graciet JC; Mourier N; Chermann JC; Kraus JL J Med Chem; 1994 Jul; 37(14):2216-23. PubMed ID: 8035429 [TBL] [Abstract][Full Text] [Related]
11. [Is resistance of human immunodeficiency viruses (HIV) to nucleoside analogs an indication for their combined use?]. Pépin JM; Simon F; Brun-Vezinet F Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):788-93. PubMed ID: 8309722 [TBL] [Abstract][Full Text] [Related]
12. Resistance of human immunodeficiency virus type 1 to antiretroviral agents: a review. Erice A; Balfour HH Clin Infect Dis; 1994 Feb; 18(2):149-56. PubMed ID: 7512829 [No Abstract] [Full Text] [Related]
13. In vitro anti-human immunodeficiency virus activity of 2',3'-dideoxynucleosides and their effect on clonal growth of hemopoietic cells from human bone marrow. Cinatl J; Cinatl J; Rabenau H; Gümbel H; Doerr HW Arzneimittelforschung; 1993 May; 43(5):622-5. PubMed ID: 8329011 [TBL] [Abstract][Full Text] [Related]
14. Suppression of HIV production in resting lymphocytes by combining didanosine and hydroxamate compounds. Malley SD; Grange JM; Hamedi-Sangsari F; Vila JR Lancet; 1994 May; 343(8908):1292. PubMed ID: 7910296 [No Abstract] [Full Text] [Related]
15. The characterization of EIAV reverse transcriptase and its inhibition by 5'-triphosphates of 2'-deoxyuridine analogs, PFA and PAA. Tao P; Zhang X; Quan K Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):130-4. PubMed ID: 1711694 [TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenesis agent DS-4152 is a potent and selective inhibitor of HIV-1 replication in vitro. Baba M; Shigeta S; Ikeuchi T; Korenaga H; Osada Y AIDS; 1994 Jan; 8(1):43-8. PubMed ID: 7516666 [TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of clinical isolates of HIV-1 to XM323, a non-peptidyl HIV protease inhibitor. Winslow DL; Mayers D; Scarnati H; Lane J; Bincsik A; Otto MJ AIDS; 1994 Jun; 8(6):753-6. PubMed ID: 8086132 [TBL] [Abstract][Full Text] [Related]
18. Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later. Pannecouque C; Daelemans D; De Clercq E Nat Protoc; 2008; 3(3):427-34. PubMed ID: 18323814 [TBL] [Abstract][Full Text] [Related]
19. Uncharged AZT and D4T derivatives of phosphonoformic and phosphonoacetic acids as anti-HIV pronucleosides. Shirokova EA; Jasko MV; Khandazhinskaya AL; Ivanov AV; Yanvarev DV; Skoblov YS; Mitkevich VA; Bocharov EV; Pronyaeva TR; Fedyuk NV; Kukhanova MK; Pokrovsky AG J Med Chem; 2004 Jul; 47(14):3606-14. PubMed ID: 15214788 [TBL] [Abstract][Full Text] [Related]
20. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine. Törnevik Y; Eriksson S Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]